Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2). (Q40548554)
Jump to navigation
Jump to search
scientific article published on 8 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2). |
scientific article published on 8 September 2015 |
Statements
1 reference
Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2). (English)
1 reference
Jos H Beijnen
1 reference
Alfred H Schinkel
1 reference
Rolf W Sparidans
1 reference
Anita Kort
1 reference
Els Wagenaar
1 reference
8 September 2015
1 reference
1 reference
102
1 reference
200-207
1 reference
Identifiers
1 reference
1 reference